Buy Breo Ellipta 100 ug/1 fluticasone furoate and vilanterol trifenatate

Breo Ellipta 100 ug/1 is a combination inhaler containing fluticasone furoate and vilanterol trifenatate. It is used for respiratory conditions like asthma and COPD. This powder inhaler helps manage symptoms and improve breathing.

Strength

100 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0859-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Breo Ellipta 100 ug/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The inhaler combines an inhaled corticosteroid (fluticasone furoate) and a long-acting beta-agonist (vilanterol trifenatate) to reduce inflammation and relax airway muscles. This helps in managing symptoms such as wheezing, shortness of breath, and coughing. It is important to consult a healthcare provider to determine if this medication is suitable for your specific respiratory condition.

Side Effects

Common effects of using Breo Ellipta 100 ug/1 may include headache, throat irritation, and hoarseness. Some users might experience tremors, nausea, or an increased heart rate. These effects vary among individuals and typically subside as the body adjusts to the medication. If any side effects persist or worsen, it is advisable to seek medical advice.

Precautions & Warnings

Breo Ellipta 100 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their health status with their doctor before using this inhaler. Always store the inhaler in a clean, dry place and keep it out of reach of children.

Avoid Interactions

Breo Ellipta 100 ug/1 may interact with other medications, including beta-blockers, monoamine oxidase inhibitors (MAOIs), and certain antidepressants. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, consuming alcohol while using this inhaler may increase the risk of side effects. Always consult your doctor or pharmacist for personalized advice.

References

Frequently Asked Questions

Breo Ellipta 100 ug/1 is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Follow the instructions provided by your healthcare provider or the patient information leaflet. Typically, it involves inhaling the powder once daily.

Common side effects may include headache, throat irritation, hoarseness, tremors, nausea, and an increased heart rate.

Consult your healthcare provider before using Breo Ellipta 100 ug/1 if you have heart disease, as it may not be suitable for everyone.

Store the inhaler in a clean, dry place at room temperature, and keep it out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.